Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2015 1
2016 3
2017 1
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases.
Morita Y, Kamal M, Kang SA, Zhang R, Lokesh GL, Thiviyanathan V, Hasan N, Woo S, Zhao D, Leslie M, Suh S, Razaq W, Rui H, Gorenstein DG, Volk DE, Tanaka T. Morita Y, et al. Among authors: hasan n. Mol Ther Nucleic Acids. 2016 Dec 13;5(12):e399. doi: 10.1038/mtna.2016.103. Mol Ther Nucleic Acids. 2016. PMID: 27959340 Free article.
The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, Razaq W, Rui H, Tanaka T. Kang SA, et al. Among authors: hasan n. BMC Cancer. 2016 May 24;16:331. doi: 10.1186/s12885-016-2366-2. BMC Cancer. 2016. PMID: 27220365 Free PMC article.
Erratum to: The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, Razaq W, Rui H, Tanaka T. Kang SA, et al. Among authors: hasan n. BMC Cancer. 2016 Jun 28;16(1):370. doi: 10.1186/s12885-016-2391-1. BMC Cancer. 2016. PMID: 27353033 Free PMC article. No abstract available.
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
Gharbaran R, Goy A, Tanaka T, Park J, Kim C, Hasan N, Vemulapalli S, Sarojini S, Tuluc M, Nalley K, Bhattacharyya P, Pecora A, Suh KS. Gharbaran R, et al. Among authors: hasan n. J Hematol Oncol. 2013 Aug 29;6:62. doi: 10.1186/1756-8722-6-62. J Hematol Oncol. 2013. PMID: 23988031 Free PMC article.